快速訂購

SUMO1/SUMO-1  Protein, Antibody, ELISA Kit, cDNA Clone

表達宿主: E. coli  
13095-H07E-50
13095-H07E-20
50 µg 
20 µg 
Add to Cart
  • Slide 1

SUMO1/SUMO-1 相关研究领域

SUMO1/SUMO-1 相關信號通路

SUMO1/SUMO-1 相關蛋白、抗體、cDNA基因、ELISA試劑盒

SUMO1/SUMO-1 概述&蛋白信息

SUMO1/SUMO-1 研究背景

基因概述: SUMO1 gene encodes a protein that is a member of the SUMO (small ubiquitin-like modifier) protein family. It functions in a manner similar to ubiquitin in that it is bound to target proteins as part of a post-translational modification system. However, unlike ubiquitin which targets proteins for degradation, this protein is involved in a variety of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. It is not active until the last four amino acids of the carboxy-terminus have been cleaved off. Several pseudogenes have been reported for SUMO1 gene. Alternate transcriptional splice variants encoding different isoforms have been characterized. [provided by RefSeq, Jul 2008]
General information above from NCBI
亞單位結構: Interacts with SAE2, RANBP2, PIAS1 and PIAS2. Interacts with PARK2. Covalently attached to a number of proteins such as IKFZ1, PML, RANGAP1, HIPK2, SP100, p53, p73-alpha, MDM2, JUN, DNMT3B and TDG. Also interacts with HIF1A, HIPK2, HIPK3, CHD3, EXOSC9, RAD51 and RAD52. Interacts with USP25 (via ts SIM domain); the interaction weakly sumoylates USP25. Interacts with SIMC1, CASP8AP2, RNF111 AND SOBP (via SIM domains). Interacts with BHLHE40/DEC1. Interacts with RWDD3. Interacts with UBE2I/UBC9 and this interaction is enhanced in the presence of RWDD3. Interacts with MTA1. {ECO:0000269|PubMed:10961991, ECO:0000269|PubMed:12565818, ECO:0000269|PubMed:12924945, ECO:0000269|PubMed:15296745, ECO:0000269|PubMed:15608651, ECO:0000269|PubMed:15660128, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:16204249, ECO:0000269|PubMed:16712526, ECO:0000269|PubMed:16955485, ECO:0000269|PubMed:17099698, ECO:0000269|PubMed:17956732, ECO:0000269|PubMed:18538659, ECO:0000269|PubMed:21829689, ECO:0000269|PubMed:21965678, ECO:0000269|PubMed:23086935}.
亞細胞定位: Nucleus membrane. Nucleus speckle. Cytoplasm. Nucleus, PML body. Note=Recruited by BCL11A into the nuclear body. {ECO:0000250}.
翻譯後修飾: Cleavage of precursor form by SENP1 or SENP2 is necessary for function.; Polymeric SUMO1 chains undergo polyubiquitination by RNF4.
相關疾病 : DISEASE: Non-syndromic orofacial cleft 10 (OFC10) [MIM:613705]: A birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum. {ECO:0000269|PubMed:16990542}. Note=The disease is caused by mutations affecting the gene represented in this entry. A chromosomal aberration involving SUMO1 is the cause of OFC10. Translocation t(2;8)(q33.1;q24.3). The breakpoint occurred in the SUMO1 gene and resulted in haploinsufficiency confirmed by protein assays.
相似的序列: Belongs to the ubiquitin family. SUMO subfamily. {ECO:0000305}.; Contains 1 ubiquitin-like domain. {ECO:0000255|PROSITE-ProRule:PRU00214}.
General information above from UniProt

Small ubiquitin-like modifier protein (SUMO) modification is a highly dynamic process, catalyzed by SUMO-specific activating (E1), conjugating (E2) and ligating (E3) enzymes, and reversed by a family of SUMO-specific proteases (SENPs). Small ubiquitin-like modifier 1 (SUMO1) is a member of the superfamily of ubiquitin-like proteins. Despite its structural similarity with ubiquitin, SUMO1 does not seem to play any role in protein degradation. SUMO1 plays an important role in modulation of NOX activity required for ROS generation. SUMO1 haploinsufficiency results in cleft lip and palate in animal models. SUMO1 gene variation in human non-syndromic cleft lip with or without cleft palate (NSCLP) development. SUMO-1 may be useful as a novel target for therapy in oral squamous cell carcinoma (SCC) as well as a clinical indicator for tumor recurrence together with Mdm2.

SUMO1/SUMO-1 別稱

DAP1,GMP1,PIC1,SMT3,UBL1,OFC10,SENP2,SMT3C,SMT3H3, [homo-sapiens]
DAP1,OFC10,GMP1,PIC1,SENP2,SMT3,SMT3C,SMT3H3,SUMO-1,UBL1,OK/SW-cl.43,SUMO1, [human]
GMP1,PIC1,MGC103203,SENTRIN,Smt3C,SMT3H3,SMTP3,Sumo1,Ubl1,SMT3,SUMO-1, [mouse]
GMP1,PIC1,SMT3,Ubl1,SMTP3,Smt3C,SMT3H3,SUMO-1,SENTRIN, [mus-musculus]

SUMO1/SUMO-1 相關文獻

  • Kim HJ, et al. (2011) SUMO1 attenuates stress-induced ROS generation by inhibiting NADPH oxidase 2. Biochem Biophys Res Commun. 410(3): 555-62.
  • Zuo Y, et al. (2009) Small ubiquitin-like modifier protein-specific protease 1 and prostate cancer. Asian J Androl. 11(1): 36-8.
  • Song T, et al. (2008) SUMO1 polymorphisms are associated with non-syndromic cleft lip with or without cleft palate. Biochem Biophys Res Commun. 377(4): 1265-8.
  • Katayama A, et al. (2007) Overexpression of small ubiquitin-related modifier-1 and sumoylated Mdm2 in oral squamous cell carcinoma: possible involvement in tumor proliferation and prognosis. Int J Oncol. 31(3): 517-24.
  • 請注意:所有產品都是“僅用於科研,而不能用於診斷或治療用途”